New CGM device aims to simplify diabetes management
Disease control
ENROLLING_BY_INVITATION
This study is testing a new continuous glucose monitor (CGM) called the iCan o3 in 70 adults with type 1 or type 2 diabetes. Participants will wear the device for 60 days to see if it improves their blood sugar control, especially the time spent in a healthy range. The goal is to…
Phase: NA • Sponsor: Sinocare • Aim: Disease control
Last updated Jun 27, 2026 08:11 UTC